More articles from Articles

Selenite-induced p53 Ser-15 phosphorylation and caspase-mediated apoptosis in LNCaP human prostate cancer cells
Cheng Jiang, Hongbo Hu, Barbara Malewicz, Zaisen Wang, Junxuan Lü

Molecular Cancer Therapeutics Jul 2004, 3 (7) 877-884;
Involvement of base excision repair in response to therapy targeted at thymidylate synthase
Li Li, Sondra H. Berger, Michael D. Wyatt

Molecular Cancer Therapeutics Jun 2004, 3 (6) 747-753;
Identification of 4-anilino-3-quinolinecarbonitrile inhibitors of mitogen-activated protein/extracellular signal-regulated kinase 1 kinase
Robert Mallon, Larry Feldberg, Steven Kim, Karen Collins, Donald Wojciechowicz, Constance Kohler, Diana Kovacs, Carolyn Discafani, Nan Zhang, Biqi Wu, Brawner Floyd, Dennis Powell, Dan Berger

Molecular Cancer Therapeutics Jun 2004, 3 (6) 755-762;
Small interfering RNA urokinase silencing inhibits invasion and migration of human hepatocellular carcinoma cells
Alessandro Salvi, Bruna Arici, Giuseppina De Petro, Sergio Barlati

Molecular Cancer Therapeutics Jun 2004, 3 (6) 671-678;
Human apurinic endonuclease 1 (APE1) expression and prognostic significance in osteosarcoma: Enhanced sensitivity of osteosarcoma to DNA damaging agents using silencing RNA APE1 expression inhibition
Dong Wang, Meihua Luo, Mark R. Kelley

Molecular Cancer Therapeutics Jun 2004, 3 (6) 679-686;
Transcriptional targeting in renal cancer cell lines via the human CXCR4 promoter
Yosef S. Haviv, Winan J. van Houdt, Baogen Lu, David T. Curiel, Zeng B. Zhu

Molecular Cancer Therapeutics Jun 2004, 3 (6) 687-691;
The p65 subunit of nuclear factor-κB is a molecular target for radiation sensitization of human squamous carcinoma cells
Kyoung M. Kim, Yin Zhang, Bo-Yeon Kim, Sook J. Jeong, Sung A. Lee, Gun-Do Kim, Anatoly Dritschilo, Mira Jung

Molecular Cancer Therapeutics Jun 2004, 3 (6) 693-698;
X-linked inhibitor of apoptosis protein inhibition induces apoptosis and enhances chemotherapy sensitivity in human prostate cancer cells
Adams Amantana, Carla A. London, Patrick L. Iversen, Gayathri R. Devi

Molecular Cancer Therapeutics Jun 2004, 3 (6) 699-707;
Nitric oxide prodrugs and metallochemotherapeutics: JS-K and CB-3-100 enhance arsenic and cisplatin cytolethality by increasing cellular accumulation
Jie Liu, Chengxiu Li, Wei Qu, Elaine Leslie, Challice L. Bonifant, Gregory S. Buzard, Joseph E. Saavedra, Larry K. Keefer, Michael P. Waalkes

Molecular Cancer Therapeutics Jun 2004, 3 (6) 709-714;
Aryl hydrocarbon receptor activation of an antitumor aminoflavone: Basis of selective toxicity for MCF-7 breast tumor cells
Andrea I. Loaiza-Pérez, Susan Kenney, Jamie Boswell, Melinda Hollingshead, Michael C. Alley, Curtis Hose, Henry P. Ciolino, Grace C. Yeh, Jane B. Trepel, David T. Vistica, Edward A. Sausville

Molecular Cancer Therapeutics Jun 2004, 3 (6) 715-725;

Main menu

User menu

Search

More articles from Articles

Pages

Articles

Info for

About MCT